Frankfurt - Delayed Quote EUR
Ovid Therapeutics Inc. (1OT.F)
0.1960
-0.0120
(-5.77%)
At close: 8:04:03 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 11.58M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| RONA JEFFREY A Chief Financial Officer | Sale at price 0.56 per share. | Direct | 2,185 | Feb 26, 2025 |
| ALEXANDER MARGARET A. President | Sale at price 0.56 per share. | Direct | 2,956 | Feb 26, 2025 |
| RONA JEFFREY A Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| ALEXANDER MARGARET A. President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| ALEXANDER MARGARET A. President | Purchase at price 0.73 per share. | Direct | 4,971 | Jan 27, 2025 |
| LEVIN JEREMY M Chief Executive Officer | Purchase at price 2.76 per share. | Direct | 50,364 | Mar 18, 2024 |
| RONA JEFFREY A Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
| PERONE THOMAS MICHAEL General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
| TARDIO JASON Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2024 |
| LEVIN JEREMY M Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 4, 2023 |
Related Tickers
RXK3.F SELLAS Life Sciences Group, Inc.
1.1760
+8.89%
1VT.MU Viking Therapeutics Inc
22.37
+7.65%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
BCAX Bicara Therapeutics Inc.
15.51
+12.23%
MBX MBX Biosciences, Inc.
8.99
+4.05%
SEPN Septerna, Inc.
6.14
+2.85%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%